SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028218
Filing Date
2018-11-08
Accepted
2018-11-07 21:22:09
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 NKTR-10-Q-20180930 nktr-10q_20180930.htm 10-Q 1618180
2 EX-31.1 nktr-ex311_9.htm EX-31.1 16075
3 EX-31.2 nktr-ex312_6.htm EX-31.2 16087
4 EX-32.1 nktr-ex321_7.htm EX-32.1 7784
  Complete submission text file 0001564590-18-028218.txt   5483183

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20180930.xml EX-101.INS 1049106
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20180930.xsd EX-101.SCH 49425
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20180930_cal.xml EX-101.CAL 43005
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20180930_def.xml EX-101.DEF 155134
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20180930_lab.xml EX-101.LAB 338266
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20180930_pre.xml EX-101.PRE 254944
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 181167941
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1